[Club-based drug use and its associated risk factors among HIV-positive methadone maintenance treatment clients].
OBJECTIVE
To describe club-based drug use and to explore the determinants on those HIV-positive methadone maintenance treatment (MMT) clients.


METHODS
This study was conducted in 5 MMT clinics in Yunnan province and 612 MMT clients who met the survey criteria were recruited for the study. Urine sample was tested as a biological marker to identify if heroin, methamphetamine, methylene-dioxy-methyl-amphetamine, buprenorphine or benzodiazepine had been used.


RESULTS
The average age among the 612 clients was 38.9 ± 6.3 years. Among these, 78.9% were males, with the average years of education as 8.0 ± 3.4 years. There were 60.5% clients who had good relationship with their families. 153 (25.0%) clients reported having used club-related drugs in the last 12 months. Results from the urine test showed that the positive rate on morphine was 14.4%, while the positive rate for club-related drugs was 26.6%. Factors as residential area, casual sexual partners, retention on MMT and occasionally use of heroin were associated with urine results on club-related drugs and the prevalence of self-reported club drug use (P < 0.05).


CONCLUSIONS
Club-related drug use was common among HIV-positive MMT clients. Inspection and supervision for club-related drugs and the education and intervention programs on related high risk behaviors should be strengthened.
School of Public Health, Anhui Medical University, Hefei 230032, China; National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention.
Haibo
H
Jiang
National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention.
Xiaobin
X
Cao
National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention.
Changhe
C
Wang
National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention.
Wei
W
Luo
National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention.
Keming
K
Rou
Yunnan Institute for Drug Abuse.
Jianhua
J
Li
Yunnan Institute for Drug Abuse.
Bo
B
Zhang
School of Public Health, Anhui Medical University, Hefei 230032, China; National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention. Email: wuzy@263.net.
Zunyou
Z
Wu
D000328:Adult; D002681:China / Q000453:epidemiology; D005260:Female; D006679:HIV Seropositivity / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D008297:Male; D008691:Methadone / Q000627:therapeutic use*; D008875:Middle Aged; D058850:Opiate Substitution Treatment; D012307:Risk Factors; D019966:Substance-Related Disorders / Q000453:epidemiology*
D008691:Methadone